80 related articles for article (PubMed ID: 32327462)
1. A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma.
Roland CL; Nassif Haddad EF; Keung EZ; Wang WL; Lazar AJ; Lin H; Chelvanambi M; Parra ER; Wani K; Guadagnolo BA; Bishop AJ; Burton EM; Hunt KK; Torres KE; Feig BW; Scally CP; Lewis VO; Bird JE; Ratan R; Araujo D; Zarzour MA; Patel S; Benjamin R; Conley AP; Livingston JA; Ravi V; Tawbi HA; Lin PP; Moon BS; Satcher RL; Mujtaba B; Witt RG; Traweek RS; Cope B; Lazcano R; Wu CC; Zhou X; Mohammad MM; Chu RA; Zhang J; Damania A; Sahasrabhojane P; Tate T; Callahan K; Nguyen S; Ingram D; Morey R; Crosby S; Mathew G; Duncan S; Lima CF; Blay JY; Fridman WH; Shaw K; Wistuba I; Futreal A; Ajami N; Wargo JA; Somaiah N
Nat Cancer; 2024 Apr; 5(4):625-641. PubMed ID: 38351182
[TBL] [Abstract][Full Text] [Related]
2. Potential for Treatment of Glioblastoma: New Aspects of Superparamagnetic Iron Oxide Nanoparticles.
Marekova D; Turnovcova K; Sursal TH; Gandhi CD; Jendelova P; Jhanwar-Uniyal M
Anticancer Res; 2020 Nov; 40(11):5989-5994. PubMed ID: 33109536
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA expression profiling and bioinformatic analysis of cumulus cells in endometriosis infertility patients.
Wu R; Li J; Li J; Yan X; Zhou W; Ling C; Ye Y; Chen Q; Li Y
Epigenomics; 2020 Dec; 12(23):2093-2108. PubMed ID: 33090019
[No Abstract] [Full Text] [Related]
4. Association between intelligent quotient and oral health conditions among 13-15 year old intellectually disabled children.
Sukhabogi JR; Doshi D; Shwetha S; Gone H; Vasavi K; Shulamithi P
Int J Adolesc Med Health; 2022 Dec; 34(6):411-415. PubMed ID: 32887188
[TBL] [Abstract][Full Text] [Related]
5. Extranodal Follicular Dendritic Cell Sarcoma-A Review: "What the Mind Does Not Know the Eye Does Not See".
Kaur R; Mehta J; Borges A
Adv Anat Pathol; 2021 Jan; 28(1):21-29. PubMed ID: 32991350
[TBL] [Abstract][Full Text] [Related]
6. A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas.
Monga V; Skubitz KM; Maliske S; Mott SL; Dietz H; Hirbe AC; Van Tine BA; Oppelt P; Okuno S; Robinson S; O'Connor M; Seetharam M; Attia S; Charlson J; Agulnik M; Milhem M
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32664595
[TBL] [Abstract][Full Text] [Related]
7. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
[TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary diagnosis and treatment of recurrent follicular dendritic cell sarcoma in abdomen: A case report.
Qu C; Tian X; Ma Y; Xie X; Wang M; Dong Y; Zhang J; Liu P; Yang Y
Medicine (Baltimore); 2020 Dec; 99(51):e23588. PubMed ID: 33371089
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Follow-Up of Combination Therapy with Sintilimab and Anlotinib in Gallbladder Follicular Dendritic Cell Sarcoma: A Rare Case Report.
Yan J; Zhang X; Yu L; Ye M; Chen Y
Onco Targets Ther; 2024; 17():287-295. PubMed ID: 38586813
[TBL] [Abstract][Full Text] [Related]
10. Favorable response to PD-1 inhibitor plus chemotherapy as first-line treatment for metastatic follicular dendritic cell sarcoma of the spleen: a case report.
Li J; Ren M; Bi F; Chen Y; Li Z
Front Immunol; 2023; 14():1228653. PubMed ID: 37691960
[TBL] [Abstract][Full Text] [Related]
11. Promising clinical outcome after body gamma knife radiotherapy for mediastinal follicular dendritic cell sarcoma with thoracic spine invasion and iliac metastasis: A case report and literature review.
Hu A; Chen T; Dong J
Front Oncol; 2022; 12():919644. PubMed ID: 36185314
[TBL] [Abstract][Full Text] [Related]
12. Response of Tonsil Follicular Dendritic Cell Sarcoma to Multimodal Treatment Including Pembrolizumab: A Case Report and Literature Review.
Chen N; Ba W; Zhao D; Sheng L; Zhang X
Front Oncol; 2022; 12():816903. PubMed ID: 35299752
[TBL] [Abstract][Full Text] [Related]
13. Follicular dendritic cell sarcoma.
Facchetti F; Simbeni M; Lorenzi L
Pathologica; 2021 Oct; 113(5):316-329. PubMed ID: 34837090
[TBL] [Abstract][Full Text] [Related]
14. Unexpected Favorable Outcome to PD-1 Antibody Plus Lenvatinib in a Patient With Recurrent Intestinal Follicular Dendritic Cell Sarcoma: A Case Report and Literature Review.
Lei Y; Zhao S; Jiang M
Front Immunol; 2021; 12():653319. PubMed ID: 34566950
[TBL] [Abstract][Full Text] [Related]
15. Turning 'Cold' tumors 'Hot': immunotherapies in sarcoma.
Rytlewski J; Milhem MM; Monga V
Ann Transl Med; 2021 Jun; 9(12):1039. PubMed ID: 34277839
[TBL] [Abstract][Full Text] [Related]
16. Follicular dendritic cell sarcoma and its response to immune checkpoint inhibitors nivolumab and ipilimumab.
Lee MY; Bernabe-Ramirez C; Ramirez DC; Maki RG
BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32327462
[TBL] [Abstract][Full Text] [Related]
17. Association Between Sex and Immune Checkpoint Inhibitor Outcomes for Patients With Melanoma.
Jang SR; Nikita N; Banks J; Keith SW; Johnson JM; Wilson M; Lu-Yao G
JAMA Netw Open; 2021 Dec; 4(12):e2136823. PubMed ID: 34854905
[TBL] [Abstract][Full Text] [Related]
18. Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors.
Wong JSL; Kwok GGW; Tang V; Li BCW; Leung R; Chiu J; Ma KW; She WH; Tsang J; Lo CM; Cheung TT; Yau T
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33563773
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
